Advancing precision psychiatry and targeted treatments: Insights from immunopsychiatry.

Saved in:
Bibliographic Details
Title: Advancing precision psychiatry and targeted treatments: Insights from immunopsychiatry.
Authors: Miller AH; Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: amill02@emory.edu., Berk M; Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine and Barwon Health, Deakin University, Geelong, VIC 3220, Australia., Bloch G; National Museum of Natural History of France, Paris, France., Briquet-Laugier V; Fondation FondaMental, Créteil, France., Brouillon C; BMD Human Pharma C.H. Boehringer Sohn AG & Co, KG Binger Str. 173 55216, Ingelheim am Rhein, Germany., Cuthbert BN; National Institute of Mental Health, Bethesda, MD, USA., Dantzer R; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Davis MC; Usona Institute, Fitchburg, WI, USA., De Picker LJ; Collaborative Antwerp Psychiatric Research Institute, University of Antwerp, Antwerp, Belgium., Drevets WC; Janssen Research & Development, LLC, of Johnson & Johnson, San Diego, CA, USA., Eyre HA; Neuro-Policy Program, Center for Health and Biosciences, The Baker Institute for Public Policy, Rice University, Houston, TX, USA., Hack LM; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA., Harrison NA; Division of Psychological Medicine and Clinical Neuroscience, Cardiff University, Cardiff, UK., Krystal AD; Department of Psychiatry, University of California, San Franscisco Weill Institute for Neurosciences, San Francisco, CA, USA., Lombardo G; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, Maurice Wohl Clinical Neuroscience Institute, King's College London, UK., Mondelli V; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, Maurice Wohl Clinical Neuroscience Institute, King's College London, UK., Pariante CM; Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, UK., Pulvirenti L; Neuroscience School of Advanced Studies, London, UK., Salvadore G; Clinical Development, Alector, Bethesda, MD, USA., Sforzini L; Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, Maurice Wohl Clinical Neuroscience Institute, King's College London, UK., Swieboda P; NeuroCentury, Brussels, Belgium., Trivedi MH; Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA., Leboyer M; Univ Paris Est Créteil, INSERM U955, IMRB, Translational NeuroPsychiatry Laboratory, Fondation FondaMental, Créteil, France.
Source: Brain, behavior, and immunity [Brain Behav Immun] 2025 Mar; Vol. 125, pp. 319-329. Date of Electronic Publication: 2025 Jan 17.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8800478 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2139 (Electronic) Linking ISSN: 08891591 NLM ISO Abbreviation: Brain Behav Immun Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1090-2139
DOI:10.1016/j.bbi.2025.01.002